Cannabis
DisposeRx Announces the Expansion of DisposeRx Direct at Rx Summit 2022
DisposeRx, Inc. will begin offering products from Rx Destroyer on its online store, DisposeRx Direct, at the Rx Drug Abuse and Heroin Summit (Rx Summit), April 18-21, 2022, in Atlanta.
Rx Summit is the largest, most influential annual conference addressing the opioid and addiction crisis, and DisposeRx is a gold sponsor. This year’s theme is “It’s Time to Turn This Epidemic Around,” and DisposeRx and Rx Destroyer executives are teaming up to help battle the drug misuse epidemic through medication disposal and education.
“DisposeRx and Rx Destroyer are coming together to share with conference participants comprehensive medication disposal options designed to meet virtually all needs—from individual prescriptions to large quantities,” said William Simpson, president and chief executive officer of DisposeRx, Inc. “We share the same mission, commitment to outstanding customer service and passion for this industry, and we are proud to work together to remove the risks and dangers associated with unused and leftover medications.”
DisposeRx Direct—a wholly-owned subsidiary of DisposeRx, Inc., now includes several of Rx Destroyer’s most popular disposal solutions for large quantities of medications. The companies will showcase their products in Booth 319.
“Rx Summit is a chance to show the world that two businesses that share marketspace can come together for the greater good and especially in the fight to end opioid abuse,” said Milton Dallas, CEO for Rx Destroyer. “Showcasing our products together demonstrates that there are several ways to make a difference, and we must have the will and courage to do so. Some things are bigger than just what is in front of us. Making the world a better place for our loved ones for generations to come is our obligation and responsibility, and this demonstration of both companies’ products is just one of many ways we can make this happen.”
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE5 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III